Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Monday, June 29

POTE S SSIN rakB117-29

12172 Protease inhibitors in children with HIV-infection
Jose Tomas Ramos Amador*; R. Bastero Gil; J. Saavedra Lozano;
A. Bodas; J. Ruiz-Contreras; J. Alcami, Spain
12173 Experience with ritonavir in HIV+ pediatric patients
Patricia Col*; Pedro Cahn; M.J. Rolon; S. Perez Macri; F. Vesperoni;
M. Avila; P. Martinez; D. Liberatore, Argentina
12174 The effect of HIV on gastro-enteritis in children admitted to a large
urban hospital in South Africa
Saul Johnson*; W. Hendson, South Africa
12175 Soroconvertion in infants of positive mothers to HIV Total
breastfeeding impact
Maria Teresa Nishimoto*; A.S.P. Gibbons; A.M. Segall-Corrna;
K.M. Teruya; R.L. Hayden, Brazil
12176 The 24-Hour hormonal profile in HIV-infected children
Mariangela Rondanelli*; D. Caselli; A. Maccabruni; M. Maghnie;
S.B. Solerte; E. Ferrari; L. Minoli, Italy
12177 Efficacy of switching to continuous intravenous AZT therapy
in oral AZT treated children with HIV encephalopathy
Vincent Guigonis*; Catherine Dollfus; V. Guigonis; D. Douard;
M. Damay; P. Ferre; F. Aubier; C. Courpotin, France
12178 Molecular characterization of human inmunodeficiency virus
type 1-infected individuals from Bolivia reveals presence of two
distinct genetic subtypes
Kety 6. Velarded*; Monica L. Guimaraes; Raul A. Arevalo;
Mariza G. Morgado, Bolivia
12179 Pediatric AIDS in a Brazilian Population: 12 years of follow-up
Heloisa Helena Marques*; Marcelo G. Vallada; H.K. Sato; M.Z. Aquino;
M.C.A. Moreira; A.S. Grumach; P. T. Sakane, Brazil
12180 Different rates of CD69, CD25, HLA-DR and CD45RO
expression, Interleukin-2 synthesis and apoptosis in
fresh or cultured lymphocytes from HIV-infected children
Constantin Voiculescu*; C. Avramescu; E. Radu; M. Balasoiu;
A. Turculeanu, Romania
12181 Neurologic manifestations in a Puertorican pediatric HIV-infected
population
Ivonne Fraga*; M. Vazquez, USA
12182 Two antiretroviral drugs regime eficacy followed by the
use of progression predictors
Adrian loan Toma*; Adina Elena Stancescu, Romania
12183 HIV/AIDS infection characterization of the pediatric patients
attending the University Hospital, Honduras
Maribel Rivera Medina*; J. Alger; RJ. Soto, Honduras
12184 CD4and CD8 response within one year after primary HIV-1 infection with
a zidovudine (AZT)-resistant strain
Vanhems, Philippe; Gaudet, R; Yerly, S; Imrie, A; Rouleau, D; Conway,
B; Cooper, Da
12185 Rapid reconstitution of the T Cell Receptor (TCR) repertoire following
antiretroviral treatment during primary HIV-infection
Rafick-Pierre Sekaly*; N. Ringuette; J. Locaille;.P. Routy; D.D. Ho;
M. Markowitz; B. Conway, Canada

12186 Primary HIV-1 infection: Clinical manifestations among women in
Mombasa, Kenya
Ludo Lavreys*; H. Martin; K. Manoaliya; J. Bwayo; J. Nainya-Achola;
J. Kreiss, Kenya
12187 The PRIMO cohort: Preliminary results from 55 patients enrolled
during primary infection in France since 1996-1997
Chritiane Deveau*; lJean-Fran(ois Delfraissy; N. N'go; I. Pellegrin;
M. Harzic; C. Rouzioux; L. Neyer, France
12188 Can durable viral suppression in patients with primary HIV-infection
using HAART lead to HIV eradication?
Li Ean Goh*; L. Perrin; D. Cooper; C. Tsoukas; B. Hoen; H. Gaines;
S. Kinloch, UK
12189 Human CD8+ T-cell differentiation in acute viral and chronic
HIV-1 infection: Persistently expanded memory populations
Maryke Th. L. Roos*; R.A. W. van Lier; D. Hamann; L. Dekker;
J.M.A. Lange; F. Miedema; P.T.A. Schellekens, The Netherlands
12190 NaiveT cell subsets during acute infection (Al) with HIV and
response to highly active antiretroviral therapy (HAART)
Sabine Kinloch-De Loes*; R.S. Tilling; W. Turnbull; M. Tyrer;
M.A. Johnson; G. Janossy, UK
12191 Suppression of viremia and immune reconstitution in seroconverting
patients receiving triple antiviral therapy
L.U.C. Perrin*; Gerard Alphonse Schocknel; C. Fagard; J.P. Chave;
D. Kaufmann; S. Yerly; B. Hirschel; L. Perrin, Switzerland
12192 Acute primary HIV-infection (APHI): A cohort description
Liliana Puga*; H. Jauregui Rueda; A. Monticelli; S.M. Oliva;
M. Burgos; A. Molina; J. Benetucci, Argentina
12193 Immunological and virological effects of combination antiretroviral
therapy: Primary HIV-infection (PHI) vs asymptomatic, established
infection (AEI)
Andrew Carr*; J. Zaunders; P. Cunningham; G. Kaufmann;
A. Kelleher; D.A. Cooper, Australia
12194 T lymphocyte dynamics in primary HIV-infected patients treated with
HAART
Nicolas Sachsenberg*; G.A. Schockmel; L. Perrin, Switzerland
12195 Neurological symptoms during primary HIV-infection correlate with
high levels of HIV-RNA in cerebral spinal fluid
Giuseppe Tambussi*; A. Gori; B. Capiluppi; C. Ballota; L. Papagno;
A. Saracco; A. Lazzarin, Italy
NOTES

IUE

CONFERENCE WORKBOOK

29